PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.
http://www.peervoice.com
Tina Vilsbøll, MD, DMSc - Overcoming Barriers to Basal Insulin in T2DM: Appreciating the Preferences and Perspectives of Patients With T2DM
Visit https://www.peervoice.com/SUE860 to view the entire programme with slides. After completing “Tina Vilsbøll, MD, DMSc - Overcoming Barriers to Basal Insulin in T2DM: Appreciating the Preferences and Perspectives of Patients With T2DM ”, participants will be able to: Explain the rationale for timely initiation of basal insulin treatment in patients with type 2 diabetes mellitus (T2DM); Assess common patient- and provider-level barriers to the use of basal insulin therapy; and Evaluate the current evidence for once-weekly insulins in the management of T2DM.